Get started
Author

Mu‐Sen Liu

Observed names: Mu-Sen Liu, Mu-Sen Liu (20983007)
ORCID: 0000-0002-3220-9330
Observed ORCID: 0000-0002-3220-9330
OpenAlex ID: A5020101101
Structural basis for mismatch surveillance by CRISPR–Cas9
2022 · Jack P. K. Bravo, Mu-Sen Liu, et al. · Nature · 276
Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA
2020 · Mu-Sen Liu, Shanzhong Gong, et al. · Nature Communications · 102
PDF
Kinetic characterization of Cas9 enzymes
2019 · Mu-Sen Liu, Shanzhong Gong, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 15
Structural Mechanism for the Fidelity Modulation of DNA Polymerase λ
2016 · Mu-Sen Liu, Hsin-Yue Tsai, et al. · Journal of the American Chemical Society · 15
PDF
Thermococcus sp. 9°N DNA polymerase exhibits 3′-esterase activity that can be harnessed for DNA sequencing
2019 · Shiuan-Woei LinWu, Yu-Hsuan Tu, et al. · Communications Biology · 11
PDF
Publisher Correction: Structural basis for mismatch surveillance by CRISPR–Cas9
2022 · Jack P. K. Bravo, Mu-Sen Liu, et al. · Nature · 7
PDF
Structural Analysis of Glycine Sarcosine N-methyltransferase from Methanohalophilus portucalensis Reveals Mechanistic Insights into the Regulation of Methyltransferase Activity
2016 · Yi-Ru Lee, Te-Sheng Lin, et al. · Scientific Reports · 7
PDF
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al. · Molecular Cancer Therapeutics · 6
PDF
A duplexed high-throughput mass spectrometry assay for bifunctional POLB polymerase and lyase activity
2024 · Zachary A. Gurard-Levin, Brian McMillan, et al. · SLAS TECHNOLOGY · 4
Genetic and biochemical screens identify MGAT1 as a druggable glycosyltransferase target in STK11-mutant lung cancer
2026 · Kiera M. Vassallo, Ying-nan P. Chen, et al. · Journal of Biological Chemistry
Supplementary Figure S2 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2026 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S6 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2026 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S4 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2026 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S7 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2026 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S1 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2026 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S3 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2026 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S5 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2026 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Abstract C104: Hit finding and assay enablement for MGAT1, a novel glycosyl transferase involved in cancer cell immune evasion
2025 · Katarzyna B. Handing, Mu-Sen Liu, et al. · Molecular Cancer Therapeutics
Supplementary Figure S6 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Data from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S1 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S2 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S7 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S5 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Supplementary Figure S4 from LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
2025 · Lauren Catherine M. Martires, Leanne G. Ahronian, et al.
Works count: 31
Citation count: 443
H-index: 7
I10-index: 5
Year
Topic
Type